Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers Meeting Abstract

  

Authors:	Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
Abstract Title:	Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers
Meeting Title:	15th World Conference on Lung Cancer (IASLC)
Keywords:	survival; chemotherapy; fusion; ret
Journal Title:	Journal of Thoracic Oncology
Volume:	8
Issue:	Suppl. 2
Meeting Dates:	2013 Oct 27-31
Meeting Location:	Sydney, Australia
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2013-11-01
Start Page:	S902
End Page:	S903
Language:	English
ACCESSION:	WOS:000339624904181
PROVIDER:	wos
DOI:	10.1097/01.JTO.0000438438.14562.c8
Notes:	Meeting Abstract: P2.11-026 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/65543